Spectrum online blood glucose analyzer and insulin pump control method

Abstract

The invention discloses a spectrum online blood glucose analyzer and an insulin pump control method, and relates to an insulin pump therapeutic instrument for diabetic patients. The spectrum online blood glucose analyzer and the insulin pump control method are invented mainly for solving problems that an existing insulin pump can only reflect a blood glucose condition at the time of blood samplingand cannot continuously measure a blood glucose level. A blood glucose concentration in a human body is analyzed and measured on line in vitro by utilizing a spectrum on-line analysis technology, andan insulin infusion dosage is adjusted and a treatment scheme is optimized according to continuous detection and analysis data of an on-line analyzer in combination with artificial intelligence systems such as remote medical support and the like. The data are transmitted to a central module through a wireless data network, the central module controls a program controller PLC, and then the PLC regulates and controls operation of an insulin pump. The insulin pump, insulin storage bottles and the program controller PLC are integrated in a portable box body, and two or more insulin storage bottles are arranged in the box body, so that the invention has advantages that online switching of insulin types can be carried out at any time according to treatment requirements, and an optimal treatmenteffect is achieved.

Description

Technical field: [0001] The invention relates to an insulin pump therapeutic instrument for diabetic patients. Background technique: [0002] Diabetes is a chronic disease that is extremely harmful to the population and is one of the four major non-communicable diseases identified by the World Health Organization. The incidence rate is increasing year by year, and the growth rate is accelerating. According to the treatment report released by the International Diabetes Federation in 2011, 336 million adults in the world have been diagnosed with diabetes, and 280 million adults are in pre-diabetes. Diabetic patients in China and India account for one-third of the world. According to public information released in 2019, my country currently has 114 million people with diabetes, with nearly 500 million people in the early stage, ranking first in the world. [0003] The acute and chronic complications of diabetes, especially chronic complications, can affect almost all organs of...

AI Technical Summary

Problems solved by technology

But this method also has defects and deficiencies: 1. After the patient purchases the insulin pump, he needs to take blood under the skin continuously for a period of one week, and analyze the blood sugar content (manually), and then formulate the control of the amount of insulin infusion according to the blood sugar analysis measurement results Model

Its defect is that the model can only reflect the blood sugar changes during the blood collection period, and cannot represent the blood sugar changes in the future period, which has limitations and blindness, and continuous blood collection increases the risk of infection and pain for patients

2. In order to correct blood sugar change data, this method provides a portable blood glucose meter, but the patient can only take blood intermittently with test strips and insert the blood glucose meter for detection, and it can only reflect the blood sugar situation at the time of blood collection, and cannot continuously measure blood sugar levels , cannot fully simulate physiological insulin secretion, and cannot effectively avoid peripheral hyperinsulinemia, diabetic ketoacidosis and hypoglycemia

3. High requirements for users and high price

Images